BETHESDA, Md.--(BUSINESS WIRE)--Sucampo Pharmaceuticals, Inc. (NASDAQ: SCMP) today announced that its wholly-owned European subsidiary, Sucampo Pharma Europe, Ltd. (SPE) based in Oxford, UK, has opened a branch office in Basel, Switzerland. SPE board member Dr. Alan Chalmers will oversee the office, located at Aeschenvorstadt 71, which will interact with the Swiss Agency for Therapeutic Products on planned future regulatory submissions for clinical research and product marketing.
